The last few days
- 1 July 1992
- journal article
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 9 (4), 11-13
- https://doi.org/10.1177/104990919200900403
Abstract
In the dying patient, coma is preceded by either progressive sedation or the development of the organic brain syndrome of delirium. More than one-third of dying patients experience some difficulties during the last 48 hours of life with noisy and moist breathing, pain, and agitation and restlessness the most common. The great majority of these terminal symptoms can be managed by reassurance or drug intervention. Sublingual lorazepam and continuous subcutaneous infusion of midazolam can be effective in controlling terminal restlessness.Keywords
This publication has 2 references indexed in Scilit:
- The Last 48 Hours of LifeJournal of Palliative Care, 1990
- The use of subcutaneous midazolam in the home care settingPalliative Medicine, 1989